IP Library Patent Application 14150624
Patent Application
App. No. 14/150,624

SYSTEM AND METHOD FOR DETERMINING INDIVIDUALIZED MEDICAL INTERVENTION FOR A DISEASE STATE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/150,624
Abstract

A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene expressed proteins, one or more molecular mechanisms, and/or combinations of such exhibit a change in expression compared to a reference, and identifying a non-specific disease therapy or agent capable of interacting with the genes, gene expressed proteins, molecular mechanisms, or combinations of such molecular findings that exhibited a change in expression.

Claims (16)

1 . A system for generating a report identifying a therapeutic agent for an individual with a cancer comprising:

a. one or more computer database comprising:

i. a reference value for a plurality of molecular targets;

ii. a listing of available therapeutic agents for said plurality of molecular targets;

b. a computer-readable program code for inputting individualized molecular profile test values for the plurality of molecular targets in the individual and comparing said test values with a corresponding reference value in (a)(i), and identifying any molecular targets whose test value is changed as compared to said reference value in (a)(i);

c. a computer-readable program code for accessing the database in (a) and identifying one or more therapeutic agent in (a)(ii) for the molecular targets having a change identified in (b); and

d. a computer-readable program for generating a report that comprises a listing of at least one molecular target exhibiting a change in (b) and the one or more therapeutic agent identified for the molecular targets having a change.

2 . The system of claim 1 , wherein the inputting in (b) is performed from a location that is remote from said database in (a).

3 . The system of claim 1 , wherein the inputting is performed over an internet connection.

4 . The system of claim 1 , wherein the report is in electronic or paper format.

5 . The system of claim 1 , wherein the one or more computer database further comprise data corresponding to one or more clinical trial of a molecular target.

6 . The system of claim 1 , wherein the reference value for each of the plurality of molecular targets comprises a nucleic acid and/or protein.

7 . The system of claim 1 , wherein the testing of the molecular target is performed after the individual has received drug therapy for the cancer.

8 . The system of claim 1 , wherein the molecular profile comprises assessing a cell, tissue sample, blood sample or combination thereof.

9 . The system of claim 1 , wherein the molecular profiling comprises performing a test for a gene and/or protein.

10 . The system of claim 1 , wherein the reference is obtained from one or more normal individual without the cancer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2014
From: VON HOFF, DANIEL D.; PENNY, ROBERT
To: MOLECULAR PROFILING INSTITUTE, INC.
Reel/Frame 033439/0019 →
CHANGE OF NAME Recorded Jul 31, 2014
From: MOLECULAR PROFILING INSTITUTE, INC.
To: CARIS MPI, INC.
Reel/Frame 033453/0536 →